VUNO Inc., founded in 2014, is a pioneering medical AI company based in South Korea. The company made history by developing the nation's first approved AI-powered medical device. Under the compelling slogan, "View the Invisible, Know the Unknown," VUNO introduces an array of AI-driven solutions that enhance healthcare diagnostics and decision-making.
By harnessing cutting-edge AI technology, VUNO processes a vast spectrum of medical data. This includes bio signals like ECG, respiratory rate, and blood pressure, as well as medical imaging such as X-rays, CT scans, and fundus images. This comprehensive data analysis aims to predict critical events, offering vital support to healthcare professionals.
Although specific details about VUNO's headquarters and last investment are unavailable, the company's commitment to patient-centered innovation is clear. Their overarching mission is to democratize high-quality healthcare, making it accessible globally. Investors seeking transformative companies in the health tech sector should consider VUNO's strong growth potential and innovative contributions to medical AI.